postoperative analgesia for knee arthroscopy

Intraarticular Dexmedetomidine with Bupivacaine versus bupivacaine alone for postoperative analgesia after knee arthroscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201507001048242

Enrollment

Registered

2015-02-25

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery postopertive analgesia Anaesthesia

Interventions

Bupivacaine group

Dexmedetomidine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I and II age 18-40 elective knee arthroscopy

Exclusion criteria

Exclusion criteria: Patients on chronic use of NSAID,opiates, calcium channel blockers, corticosteroids, tricyclic antidepressant. Patients with psychiatric disorders. History of gastric or duodenal ulcers. Hypersensitivity to NSAIDs, consumption of analgesics within 24 h of surgery. patients with liver or renal disease. Hypersensitivity to local anaesthesia.

Design outcomes

Primary

Measure	Time frame
VAS	—

Secondary

Measure	Time frame
Requirement of rescue analgesia , total pethidine consumption	—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

lecturer of aesthesia and surgical ICU

Shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 24, 2026